rs2953475

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000519833.5(IL7):​n.268-4463G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.336 in 151,704 control chromosomes in the GnomAD database, including 9,931 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 9931 hom., cov: 32)

Consequence

IL7
ENST00000519833.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.625

Publications

7 publications found
Variant links:
Genes affected
IL7 (HGNC:6023): (interleukin 7) The protein encoded by this gene is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL7 is found to be a cofactor for V(D)J rearrangement of the T cell receptor beta (TCRB) during early T cell development. This cytokine can be produced locally by intestinal epithelial and epithelial goblet cells, and may serve as a regulatory factor for intestinal mucosal lymphocytes. IL7 plays an essential role in lymphoid cell survival, and in the maintenance of naive and memory T cells. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional splice variants have been described but their presence in normal tissues has not been confirmed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can be a potent inducer of proinflammatory cytokines and chemokines which may defend against the infection, but may also mediate destructive lung injury. Elevated serum IL7 levels, together with several other circulating cytokines and chemokines, has been found to be associated with the severity of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Jul 2020]
IL7 Gene-Disease associations (from GenCC):
  • epidermodysplasia verruciformis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • epidermodysplasia verruciformis, susceptibility to, 5
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.528 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL7XM_011517522.4 linkc.415-4463G>T intron_variant Intron 5 of 5 XP_011515824.1
IL7XM_011517523.4 linkc.414+10571G>T intron_variant Intron 5 of 5 XP_011515825.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL7ENST00000519833.5 linkn.268-4463G>T intron_variant Intron 3 of 6 5
IL7ENST00000523959.5 linkn.122-4463G>T intron_variant Intron 2 of 4 3
ENSG00000296852ENST00000743040.1 linkn.339-25C>A intron_variant Intron 2 of 3
ENSG00000296852ENST00000743041.1 linkn.215+1714C>A intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.336
AC:
50955
AN:
151586
Hom.:
9898
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.533
Gnomad AMI
AF:
0.225
Gnomad AMR
AF:
0.265
Gnomad ASJ
AF:
0.430
Gnomad EAS
AF:
0.0966
Gnomad SAS
AF:
0.242
Gnomad FIN
AF:
0.262
Gnomad MID
AF:
0.455
Gnomad NFE
AF:
0.264
Gnomad OTH
AF:
0.353
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.336
AC:
51042
AN:
151704
Hom.:
9931
Cov.:
32
AF XY:
0.334
AC XY:
24772
AN XY:
74118
show subpopulations
African (AFR)
AF:
0.534
AC:
22088
AN:
41370
American (AMR)
AF:
0.265
AC:
4036
AN:
15222
Ashkenazi Jewish (ASJ)
AF:
0.430
AC:
1488
AN:
3462
East Asian (EAS)
AF:
0.0966
AC:
499
AN:
5164
South Asian (SAS)
AF:
0.242
AC:
1163
AN:
4810
European-Finnish (FIN)
AF:
0.262
AC:
2762
AN:
10532
Middle Eastern (MID)
AF:
0.459
AC:
134
AN:
292
European-Non Finnish (NFE)
AF:
0.264
AC:
17922
AN:
67844
Other (OTH)
AF:
0.355
AC:
747
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1625
3250
4875
6500
8125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.314
Hom.:
1062
Bravo
AF:
0.341
Asia WGS
AF:
0.231
AC:
804
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.12
DANN
Benign
0.20
PhyloP100
-0.63

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2953475; hg19: chr8-79638138; API